Inflammatory Bowel Disease Clinical Trials

A listing of Inflammatory Bowel Disease medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Alabama

Dothan Alabama 36305

A clinical trial to evaluate treatments using Apremilast and Placebo for patients with Ulcerative Colitis

Huntsville Alabama 35802

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Arizona

Scottsdale Arizona 85260

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85724

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85712

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85712

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

View More ▼

Tucson Arizona 85741

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Arkansas

Little Rock Arkansas 72205

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Little Rock Arkansas 72211

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

North Little Rock Arkansas 72117

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Sherwood Arkansas 72120

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

California

Bakersfield California 93301

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Garden Grove California 92845

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

La Jolla California 92093-0956

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

La Jolla California 92037

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

La Mirada California 90638

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

View More ▼

Laguna Hills California 92653

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Los Angeles California 90067

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Los Angeles California 90045

A clinical trial to evaluate treatments using Apremilast and Placebo for patients with Ulcerative Colitis

Los Angeles California 90045

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Mission Hills California 91345

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Northridge California 91324

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Oceanside California 92056

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Oceanside California 92056

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Orange California 92868

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Palo Alto California 94304

Patients are needed to participate in a clinical research study evaluating fecal calprotectin level for the treatment of Inflammatory Bowel Disease or Irritable Bowel Syndrome (IBS)

San Carlos California 94070

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

San Diego California 92103

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

San Diego California 92103

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

San Diego California 92103

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Torrance California 90503

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Colorado

Denver Colorado 80045

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Littleton Colorado 80120

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Connecticut

Bristol Connecticut 06010

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Bristol Connecticut 06010

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Danbury Connecticut 06810

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Plainville Connecticut 06062

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Florida

Boca Raton Florida 33428

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Boynton Beach Florida 33426

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Boynton Beach Florida 33426

A clinical trial to evaluate treatments using Apremilast and Placebo for patients with Ulcerative Colitis

Clearwater Florida 33756

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Coral Gables Florida 33173

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

View More ▼

Coral Springs Florida 33071

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Crystal River Florida 34429

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Deland Florida 32720

A clinical trial to evaluate treatments using Apremilast and Placebo for patients with Ulcerative Colitis

Hollywood Florida 33021

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Homestead Florida 33030

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Inverness Florida 34453

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Inverness Florida 34452

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis